Progress in the development and acquisition of anticancer agents from marine sources

被引：97
作者：
Amador, ML
Jimeno, J
Paz-Ares, L
Cortes-Funes, H
Hidalgo, M
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Pharmamar SA, Madrid, Spain
[3] Hosp Univ Doce Octubre, Dept Med Oncol, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2003年 / 14卷 / 11期
关键词：
aplidine; bryostatin; cancer; dolastatin; ET-743; marine;
D O I：
10.1093/annonc/mdg443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1607 / 1615
页数：9
相关论文
共 99 条
  • [1] ALLEN SLV, 1997, AM ASS CANC RES, V39, P222
  • [2] Anthoney A, 2000, P AM SOC CLIN ONCOL, V19, p189a
  • [3] ARMAND JP, 2001, P 37 ASCO ANN M SAN, V20, pA120
  • [4] BAGNIEWSKI PG, 1997, AM ASS CANC RES, V39, P221
  • [5] BANGALORE NSB, 2000, P AN M AM SOC CLIN, V19, pA193
  • [6] BEIJNEN JH, 1999, P AN M AM SOC CLIN, V18, pA163
  • [7] PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF DIDEMNIN-B IN PATIENTS WITH METASTATIC BREAST-CANCER
    BENVENUTO, JA
    NEWMAN, RA
    BIGNAMI, GS
    RAYBOULD, TJG
    RABER, MN
    ESPARZA, L
    WALTERS, RS
    [J]. INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) : 113 - 117
  • [8] IDENTIFYING SMALL-MOLECULE LEAD COMPOUNDS - THE SCREENING APPROACH TO DRUG DISCOVERY
    BEVAN, P
    RYDER, H
    SHAW, A
    [J]. TRENDS IN BIOTECHNOLOGY, 1995, 13 (03) : 115 - 121
  • [9] A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
    Blackhall, FH
    Ranson, M
    Radford, JA
    Hancock, BW
    Soukop, M
    McGown, AT
    Robbins, A
    Halbert, G
    Jayson, GC
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (04) : 465 - 469
  • [10] BOWMAN A, 2001, P AN M AM SOC CLIN, V20, pA120
12345678910